Papilledema due to Vaccine-Induced Thrombocytopenia

Ophthalmology. 2022 Feb;129(2):190. doi: 10.1016/j.ophtha.2021.07.016.

Authors

Jenn Qian¹, Carla Lutchman¹, Edward Margolin²

Affiliations

¹ Department of Ophthalmology and Visual Sciences.
² Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario.

No abstract available

Publication types

Case Reports

MeSH terms

Antithrombins / therapeutic use
Arginine / analogs & derivatives
Arginine / therapeutic use
COVID-19 / prevention & control
ChAdOx1 nCoV-19 / adverse effects*
Female
Glucocorticoids / therapeutic use
Humans
Hydrocortisone / therapeutic use
Immunoglobulins, Intravenous / therapeutic use
Middle Aged
Ophthalmoscopy
Papilledema / chemically induced*
Papilledema / diagnosis
Papilledema / drug therapy
Pipecolic Acids / therapeutic use
Purpura, Thrombocytopenic, Idiopathic / chemically induced*
Purpura, Thrombocytopenic, Idiopathic / diagnosis
Purpura, Thrombocytopenic, Idiopathic / drug therapy
SARS-CoV-2 / immunology
Sinus Thrombosis, Intracranial / chemically induced*
Sinus Thrombosis, Intracranial / diagnosis
Sinus Thrombosis, Intracranial / drug therapy
Sulfonamides / therapeutic use
Vaccination / adverse effects*

Substances

Antithrombins
Glucocorticoids
Immunoglobulins, Intravenous
Pipecolic Acids
Sulfonamides
Arginine
ChAdOx1 nCoV-19
argatroban
Hydrocortisone